RKRahul Kuver

Rahul Kuver

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rahul Kuver has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The changing faces of cholangitis

    by Sum P. Lee, Joseph R. Roberts, Rahul Kuver

    A variety of diseases are included under the umbrella term ‘cholangitis’, including hepatobiliary diseases with an autoimmune pathogenesis (such as primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-associated sclerosing cholangitis) and disease processes associated with intraductal stones and infectious etiologies (such as ascending bacterial cholangitis, recurrent pyogenic cholangitis, and liver fluke-associated cholangitis). Recent advances in the pathophysiologic bases of these disorders, particularly with respect to the autoimmune variety, are allowing improved diagnosis and prognostication as well as providing the opportunity to refine and re-imagine treatment modalities. The aim of this review is to highlight selected advances in cholangitis research that point to novel insights into the pathophysiology, diagnosis, and treatment of this diverse array of disorders.


  • Mechanisms of oxysterol-induced disease: insights from the biliary system

    by Rahul Kuver

    Oxysterols are oxidized species of cholesterol that are derived from exogenous (e.g. dietary) and endogenous (in vivo) sources. Oxysterols play critical roles in normal physiologic functions as well as in pathophysiologic processes in a variety of organ systems. This review provides an overview of oxysterol biology from the vantage point of the biliary system. Several oxysterols have been identified in human bile in the context of biliary tract infection and inflammation. This finding has led to investigations regarding the potential pathophysiologic significance of biliary oxysterols in diseases affecting the biliary system, with an emphasis on cholangiocarcinoma. Emerging evidence implicates specific oxysterols in the development and progression of this malignancy. This review will summarize the literature on oxysterols in the biliary system and discuss how the accumulated evidence contributes to a hypothesis describing the molecular basis of cholangiocarcinogenesis.


    • 1 January 2012
      • p. 77-82

    Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma.

    by Apinya Jusakul, Narong Khuntikeo, W Geoffrey Haigh, Rahul Kuver, George N Ioannou, Watcharin Loilome, Nisana Namwat, Vajarabhongsa Bhudhisawasdi, Ake Pugkhem, Chawalit Pairojkul, et al.

    Bile acids are implicated as aetiological factors in many types of gastrointestinal tract cancer including cholangiocarcinoma (CCA). Alterations in bile acid concentrations may affect the pathogenesis of these different types of cancer. Our aim was to determine the bile acid profile in gallbladder bile from patients who underwent liver resection. Thirty-seven patients with cholangiocarcinoma, 5 with hepatocellular carcinoma, and 7 with benign biliary diseases were studied. High pressure liquid chromatography was used to analyze conjugated and unconjugated bile acids. CCA patients with low (≤ 2 mg/dl) and high (>2 mg/dl) levels of total serum bilirubin had significantly higher total bile acid and conjugated bile acid concentrations than the benign biliary disease group. Markedly elevated levels of cholic and chenodeoxycholic acid were found in CCA cases with high levels of total serum bilirubin. Concentrations of total bile acids and primary bile acid were correlated with serum cholesterol, bilirubin and ALP in CCA. Notably, correlation of the carcinoembryonic antigen, a tumor marker, was found with level of total bile acids and chenodeoxycholic acid. These findings suggest a different pattern of bile acid concentration in cancer patients compared to patients with benign biliary diseases. Thus, accumulation of certain bile acids may be involved in carcinogenesis.


  • Open Access

    Effects of statins on cholestasis: Good, bad or indifferent?

    by Rahul Kuver

    See article in J. Gastroenterol. Hepatol. 2011; 26: 1544–1551.


  • Open Access

    Mechanisms of oxysterol-induced carcinogenesis

    by Apinya Jusakul, Puangrat Yongvanit, Watcharin Loilome, Nisana Namwat, Rahul Kuver

    Oxysterols are oxidation products of cholesterol that are generated by enzymatic reactions mediated by cytochrome P450 family enzymes or by non-enzymatic reactions involving reactive oxygen and nitrogen species. Oxysterols play various regulatory roles in normal cellular processes such as cholesterol homeostasis by acting as intermediates in cholesterol catabolism. Pathological effects of oxysterols have also been described, and various reports have implicated oxysterols in several disease states, including atherosclerosis, neurological disease, and cancer. Numerous studies show that oxysterols are associated with various types of cancer, including cancers of the colon, lung, skin, breast and bile ducts. The molecular mechanisms whereby oxysterols contribute to the initiation and progression of cancer are an area of active investigation. This review focuses on the current state of knowledge regarding the role of oxysterols in carcinogenesis. Mutagenicity of oxysterols has been described in both nuclear and mitochondrial DNA. Certain oxysterols such as cholesterol-epoxide and cholestanetriol have been shown to be mutagenic and genotoxic. Oxysterols possess pro-oxidative and pro-inflammatory properties that can contribute to carcinogenesis. Oxysterols can induce the production of inflammatory cytokines such as interleukin-8 and interleukin-1β. Certain oxysterols are also involved in the induction of cyclo-oxygenase-2 expression. Inflammatory effects can also be mediated through the activation of liver-X-receptor, a nuclear receptor for oxysterols. Thus, several distinct molecular mechanisms have been described showing that oxysterols contribute to the initiation and progression of cancers arising in various organ systems.


  • Effects of lipopolysaccharide on platelet‐derived growth factor isoform and receptor expression in cultured rat common bile duct fibroblasts and cholangiocytes

    by Tae‐Hyeon Kim, Jong Ho Moon, Christopher E Savard, Rahul Kuver, Sum P Lee

    Background and Aim:  Little is known about the role of platelet‐derived growth factor (PDGF) in biliary fibrosis in the setting of bacterial colonization of the biliary tree. We therefore sought to investigate whether exposure to bacterial lipopolysaccharide (LPS) alters PDGF isoform and receptor expression in cultured rat common bile duct fibroblasts (CBDF) and normal rat cholangiocytes (NRC).Methods:  Collagen content in cells and media was assessed by colorimetric assay and gel electrophoresis. mRNA levels of PDGF‐A and ‐B, and PDGF‐Receptors (PDGF‐R) α and β were measured by relative quantitative real‐time PCR. Protein levels of PDGF‐AA, AB and BB were measured by ELISA, and PDGF‐Rα and PDGF‐Rβ by Western blot.Results:  In CBDF, LPS increased total soluble collagen synthesis and secretion. PDGF‐Rα and β mRNA and protein were also increased by LPS treatment in CBDF. Lipopolysaccharide treatment elicited an increase in PDGF‐A and ‐B mRNA levels in CBDF. In NRC, levels of PDGF‐A mRNA increased in a dose‐dependent fashion following LPS treatment, whereas PDGF‐B mRNA showed no response. PDGF‐AA secretion was higher by CBDF than by NRC. PDGF‐BB levels were also higher in CBDF than in NRC. While PDGF‐BB levels did not respond to LPS treatment in CBDF, there was a dose‐dependent response of this isoform to LPS in NRC. Intracellular and secreted PDGF‐AB increased with LPS treatment in NRC.Conclusions:  These results support a model in which chronic bacterial colonization of the biliary tree induces fibrosis through PDGF‐dependent mechanisms.